Bicycle Therapeutics plc
- BCYC
- NASDAQ
- Biotechnology
- Peptide Therapeutics
- Cancer Drugs
- Toxin Conjugates
$3.54
Today +2.17%Quote Oct 19, 2026, 08:00 PM UTC
−5.98%over the last month
Max drawdown −13.7%From 1-month high −13.7%3 months −16.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Bicycle Therapeutics
Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
288
Founded
2009
Market value
$246.8M
Quote Oct 19
Analyst target
$12.00
+239.5% from here
Floor
$3.42
3.3% below price
Resistance
$3.65
3.3% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BCYCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free